Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Gujinović Diana

24 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Safety 10 Review Article 7 Depression 7 Pharmacology 7 Receptor Pharmacology 6 Clinical Trial 5 General 5 Mechanism of Action 5 Toxicity 4 Neuroplasticity 4 Randomized Controlled Trial 3 Systematic Review 3

Journals

RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia 5 Science Letters 2 Instituto Politécnico do Porto 2 Toxicology Letters 2 JAMA psychiatry 1 Psychiatry International 1 Journal of Clinical Epidemiology 1 ClinicalTrials.gov 1

Publication history

Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.JAMA psychiatry · 2026-07-01 Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-AnalysisPsychiatry International · 2026-06-15 Pure psilocybin reduces reward-associated preference while mushroom extract shows transient exploratory effects in ratsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-05-01 Preclinical evaluation of psilocybin and related compounds: Inhibition of cytochrome P450 isoformsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-05-01 Cytochrome P450 Inhibition by Psilocybin and Psilocin: A Combined Molecular Dynamics and Enzymatic Screening StudyRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2026-05-01 Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han ratsScience Letters · 2026-04-17 Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in ratsScience Letters · 2026-04-17 Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybinJournal of Clinical Epidemiology · 2026-04-01 Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use DisorderClinicalTrials.gov · 2026-03-30 Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-makingInstituto Politécnico do Porto · 2026-02-27 Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico EvidenceInstituto Politécnico do Porto · 2026-02-25 Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-20 Emerging mechanisms of psilocybin-induced neuroplasticity.Trends in pharmacological sciences · 2025-11-01 Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell ModelRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2025-01-01 The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.CNS spectrums · 2024-12-01 The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists.The American journal of psychiatry · 2024-11-01 Palliative care patients' attitudes and openness towards psilocybin-assisted psychotherapy for existential distress.Frontiers in psychiatry · 2024-01-01 Clinical specificity profile for novel rapid acting antidepressant drugs.International clinical psychopharmacology · 2023-09-01 P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applicationsToxicology Letters · 2022-09-01 P03-18 Simultaneous detection and quantification of psilocybin and psilocin by gas chromatography coupled to mass spectrometry (GC-MS)Toxicology Letters · 2022-09-01 Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanismsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-06 The noetic connection: synaesthesia, psychedelics, and languageDigital Creativity · 2004-12-31 Effects of psychodysleptic drug psilocybin on visual perception. Changes in brightness preference.Experientia · 1969-02-15 Psilocybin-induced Autonomic, Perceptual, and Behavioral ChangePharmacopsychiatry · 1968-11-01

Author directory